To date, only one drug has been approved for the treatment of itch (persistent pruritus) and it only targets a small portion of the patient population. Researchers from Mallinckrodt plc have unveiled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback